Rare pe­di­atric dis­ease vouch­ers face un­cer­tain fu­ture af­ter Sep­tem­ber

Con­gress has un­til the end of Sep­tem­ber to reau­tho­rize a vouch­er pro­gram that’s meant to in­cen­tivize new drug de­vel­op­ment for rare pe­di­atric dis­eases. But the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.